<DOC>
	<DOCNO>NCT00601679</DOCNO>
	<brief_summary>This multicentre Phase IV study patient chronic HF manage follow HF/heart function clinic follow period two year . Clinic patient recruit study obligatory blood sample surveillance measurement NT-proBNP level every three month minimum one year ( 4 sample ) . One-half subject clinic randomize NT-proBNP value make know attend clinic physician nurse , half value blind . During study , attend clinic physician order open-label NT-proBNP BNP assay , available institution , assist management patient feel clinically need .</brief_summary>
	<brief_title>Improvement Patients With Chronic Heart Failure Using NT-proBNP</brief_title>
	<detailed_description>Once eligible clinic patient identify , write informed consent obtain . All patient blood draw measurement NT-proBNP immediately consent obtain . The patient randomize either usual care NT-proBNP arm . For patient enrol study attend physician ensure obligatory blood sample measurement NT-proBNP level every three month minimum one year ( 4 sample ) . Conventional measure use programmed management setting include history taking , physical radiographic examination echocardiography also undertaken per clinical practice . Patients arm treat conventional measure . One-half subject clinic randomize NT-proBNP value make know attend clinic physician nurse practitioner . The half ( Usual Care ) value blind . During study , attend clinic physician order NT-proBNP BNP assay , available institution , assist management patient feel clinically need . Demographic variable age , gender , BMI , serum creatinine , eGFR also collect arm . A dedicated research coordinator base St. Michael 's Hospital , core centre , monitor patient , data blood sample collection participate clinic . NT-proBNP measure site clinic facility measure NT-proBNP . For clinic facility , sample ship core centre measurement result provide clinic within one week patient randomize open-label NT-proBNP . The research coordinator , via close communication clinic nurse physician , ensure process immaculately execute blinding maintain . All patient follow every three month minimum one year ( 4 sample ) include initial evaluation ( Visit 1 ) along four follow-up visit HF/heart function clinic ( Visits 2 - 5 ) . A clinic visit request patient experience serious adverse event since Visit 1 .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Age â‰¥ 18 year age NYHA class IIIV heart failure Followed program heart failure ( HF ) management set Life expectancy &lt; 1 year due cause HF advanced cancer Any condition may render patient ineligible accord investigator 's judgment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>CHF treatment &amp; prognosis , NT-proBNP testing .</keyword>
</DOC>